Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 241 to 255 of 1331 results for heart OR cardi* OR arrythmia

  1. Percutaneous laser revascularisation for refractory angina pectoris (HTG193)

    Evidence-based recommendations on percutaneous laser revascularisation for refractory angina pectoris. This involves inserting a catheter into major vessels of the groin, which is advanced to the heart, to drill holes on the heart muscle using a laser beam.

    HealthTech guidance
    Published
    27 May 2009
    View recommendations

    Sections for HTG193

  2. Dopamine: In people with acute heart failure, congestion and worsening renal function, does the addition of low‑dose dopamine to standard therapy lead to greater diuresis and renal protection compared with adding placebo to standard therapy?

    Recommendation ID CG187/01 Question Dopamine: In people with acute heart failure, congestion and worsening renal function, does the...

    Research recommendation
    Published
    16 December 2021

  3. Join our people and communities network

    Join NICE's people and communities network

  4. Join our people and communities network

    Join NICE's people and communities network

  5. Indications for interventions – global longitudinal strain: In adults with severe heart valve disease what is the prognostic value and cost effectiveness of global longitudinal strain to assess the need for intervention?

    Indications for interventions – global longitudinal strain: In adults with severe heart valve disease what is the prognostic value and...

    Research recommendation
    Published
    16 December 2021

  6. Intrabeam radiotherapy system for adjuvant treatment of early breast cancer (TA501)

    Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery in adults.

    Technology appraisal guidance
    Published
    31 January 2018
    View recommendations

    Sections for TA501

  7. Myocardial infarction: PCI rates (IND74)

    This indicator covers the time between call for help and balloon inflation for patients with ST segment elevation myocardial infarction (STEMI) undergoing reperfusion by primary percutaneous coronary intervention (PCI). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG93

    Network / system level indicators
    Published
    27 August 2021

  8. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with primary severe mitral regurgitation?

    NG208/16 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE...

    Research recommendation
    Published
    16 December 2021

  9. Hypertension in pregnancy: diagnosis and management (NG133)

    This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension. It aims to improve care during pregnancy, labour and birth for women and their babies.

    NICE guideline
    Last updated
    17 April 2023
    View recommendations

    Sections for NG133

  10. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of beta‑blockers for adults over 75 years with non‑rheumatic/calcific mitral stenosis, in both sinus rhythm and atrial fibrillation?

    NG208/17 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of...

    Research recommendation
    Published
    16 December 2021

  11. Type 2 diabetes: prevention in people at high risk (PH38)

    This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide those at high risk with an effective and appropriate intensive lifestyle-change programme to prevent or delay the onset of type 2 diabetes. The recommendations in this guideline can be used alongside the NHS Health Check programme .

    Public health guideline
    Last updated
    15 September 2017
    View recommendations

    Sections for PH38

  12. Hypertension in adults. Patient decision aid on how do I control my blood pressure? Lifestyle options and choice of medicines

    blood pressure, your heart has to work harder to pump blood around your body. This means that you may be at risk of...

  13. Contributing to the development of our guidelines

    We've created the guides and resources on this page to help people who are involved in developing NICE guidelines.

  14. Getting involved as someone with lived experience

    We want you to help NICE to develop our guidance for NHS and care services.

  15. Getting involved as someone with lived experience

    We want you to help NICE to develop our guidance for NHS and care services.